Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93(9):1137–1146

Article  PubMed  PubMed Central  Google Scholar 

Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366(1):54–63

Article  CAS  PubMed  Google Scholar 

Monzo L, Girerd N (2025) EMPACT-ing prognosis: Tailoring SGLT2i therapy with GDF-15. Int J Cardiol 431:133251

Article  PubMed  Google Scholar 

Kamon D, Sugawara Y, Soeda T, Okamura A, Nakada Y, Hashimoto Y et al (2021) Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction. ESC Heart Fail 8(1):317–325

Article  PubMed  Google Scholar 

Monzo L, Huttin O, Ferreira JP, Lamiral Z, Bozec E, Beaumont M et al (2023) Role of aldosterone in mid- and long-term left ventricular remodelling after acute myocardial infarction: The REMI study. Eur J Heart Fail 25(10):1742–1752

Article  CAS  PubMed  Google Scholar 

Al-Awar A, Khan AW, Hussain S (2025) Myocardial stunning: mechanisms, molecular insights, and gaps in knowledge. Biosci Rep. 2025 Dec 16;45(12):BSR20253410 https://doi.org/10.1042/BSR20253410

Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE (2011) Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4(1):98–108

Article  PubMed  Google Scholar 

Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G et al (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383(9932):1933–1943

Article  PubMed  PubMed Central  Google Scholar 

Felker GM, Shaw LK, O’Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39(2):210–218

Article  PubMed  Google Scholar 

Cabac-Pogorevici I, Muk B, Rustamova Y, Kalogeropoulos A, Tzeis S, Vardas P (2020) Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology. Eur J Heart Fail 22(5):789–799

Article  PubMed  Google Scholar 

Reynolds HR, Shaw LJ, Min JK, Page CB, Berman DS, Chaitman BR et al (2021) Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. Circulation 144(13):1024–1038

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin GA, Dudley RA (2014) Fighting the oculostenotic reflex. JAMA Intern Med 174(10):1621–1622

Article  PubMed  Google Scholar 

Escaned J, Banning A, Farooq V, Echavarria-Pinto M, Onuma Y, Ryan N et al (2016) Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. EuroIntervention 12(2):e224–e234

Article  PubMed  Google Scholar 

De Silva K, Morton G, Sicard P, Chong E, Indermuehle A, Clapp B et al (2013) Prognostic utility of BCIS myocardial jeopardy score for classification of coronary disease burden and completeness of revascularization. Am J Cardiol 111(2):172–177

Article  PubMed  Google Scholar 

Almeida AG, Carpenter JP, Cameli M, Donal E, Dweck MR, Flachskampf FA et al (2021) Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging 22(8):e97–e125

Article  PubMed  Google Scholar 

Garcia MJ, Kwong RY, Scherrer-Crosbie M, Taub CC, Blankstein R, Lima J et al (2020) State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association. Circ Cardiovasc Imaging 13(7):e000053

Article  PubMed  Google Scholar 

Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J et al (2011) Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 124(12):1351–1360

Article  PubMed  Google Scholar 

Alam L, Omar AMS, Patel KK (2023) Improved Performance of PET Myocardial Perfusion Imaging Compared to SPECT in the Evaluation of Suspected CAD. Curr Cardiol Rep 25(4):281–293

Article  PubMed  Google Scholar 

Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32(7):375–410

Article  PubMed  Google Scholar 

Gatti M, De Filippo O, Cura Cura G, Dusi V, Di Vita U, Gallone G et al (2025) Diagnostic accuracy of late iodine enhancement on cardiac CT for myocardial tissue characterization: a systematic review and meta-analysis. Eur Radiol 35(6):3054–3067

Article  CAS  PubMed  Google Scholar 

Kotronias RA, Portolan L, Xie C, Ferreira VM, Raman B, Klotz E et al (2026) Evaluating Acute Ischemic Myocardial Injury With Photon-Counting Computed Tomography. JACC Cardiovasc Imaging 19(2):284–287

Article  PubMed  Google Scholar 

Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 45(36):3415–3537

Article  CAS  PubMed  Google Scholar 

Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH et al (2023) 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 148(9):e9–e119

Article  PubMed  Google Scholar 

Panza JA, Ellis AM, Al-Khalidi HR, Holly TA, Berman DS, Oh JK et al (2019) Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. N Engl J Med 381(8):739–748

Article  PubMed  PubMed Central  Google Scholar 

Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M et al (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50(20):2002–2012

Article  PubMed  Google Scholar 

Ge Y, Antiochos P, Steel K, Bingham S, Abdullah S, Chen YY et al (2020) Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function. JACC Cardiovasc Imaging 13(10):2132–2145

Article  PubMed  PubMed Central  Google Scholar 

Shah DJ, Kim HW, James O, Parker M, Wu E, Bonow RO et al (2013) Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA 309(9):909–918

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M et al (2014) Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64(12):1217–1226

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895–e1032

PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 24(1):4–131

Article  PubMed  Google Scholar 

Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr., Cuddy TE et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327(10):669–677

Article  CAS  PubMed  Google Scholar 

White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S et al (2005) Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation 112(22):3391–3399

Article  CAS  PubMed  Google Scholar 

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2013) Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail 15(9):1062–1073